Dec 05, 2022 8:37am EST Ekso Bionics Announces Acquisition of Human Motion and Control Business Unit Including Indego® Product Line From Parker Hannifin Corporation
Oct 27, 2022 8:00am EDT Ekso Bionics to Report Third Quarter 2022 Financial Results on November 3, 2022
Sep 06, 2022 4:05pm EDT Ekso Bionics to Present at H.C. Wainwright 24th Annual Global Investment Conference
Jun 13, 2022 8:00am EDT Ekso Bionics Receives FDA Clearance to Market its EksoNR™ Robotic Exoskeleton for Use with Multiple Sclerosis Patients
